Calibrate
Calibrate raises $100M Series B at $1.3B valuation
Quick Facts
Calibrate: Series B Funding Round
Calibrate has successfully raised $100M in Series B funding, reaching a valuation of $1.3B.
Company Overview
Metabolic health platform
Funding Details
The Series B round was led by Founders Fund, with participation from Threshold Ventures, Optum Ventures, Tiger Global, Redesign Health.
Company Information
- Headquarters: 315 Hudson Street, New York, NY 10013
- Founded: 2020
- Employees: 300+
- Category: HealthTech
Investment
Calibrate plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Founders Fund: Verified investor in Series B
- Threshold Ventures: Verified investor in Series B
- Optum Ventures: Verified investor in Series B
- Tiger Global: Verified investor in Series B
- Redesign Health: Verified investor in Series B
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
